Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial aims to explore the safety and effectiveness of the Hyper-ERAS rehabilitation protocol for colorectal cancer patients and the feasibility of discharge within 48 hours.
The Hype-ERAS protocol includes preoperative education, intraoperative quality control, postoperative preventive analgesia, early ambulation, early recovery of diet, early removal of drainage tube, urinary catheter, and gastric tube, discharge within 48 hours after surgery, and standardized follow-up outside the hospital. Patients treated with the Hyper-ERAS rehabilitation protocol and discharged within 48 hours were in group A. Patients who were treated with Hyper-ERAS protocol and had a postoperative hospital stay of more than 48 hours were classified as group B. Patients eligible but not treated with the Hyper-ERAS rehabilitation protocol during the same period were in group C (Control group). The postoperative recovery of each group was compared to explore the safety and efficacy of Hyper-ERAS rehabilitation program in patients with colorectal cancer.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A:Hyper-ERAS(Length of Postoperative Hospital Stay<48h) | Experimental | Patients treated with the Hyper-ERAS rehabilitation protocol and discharged within 48 hours were in group A. |
|
| Group B:Hyper-ERAS(LOPS>48h) | Experimental | Patients treated with the ERAS rehabilitation protocol and discharged in more than 48 hours were in group B. |
|
| Group C:Control group | No Intervention | Patients eligible but not treated with the Hyper-ERAS rehabilitation protocol during the same period were in group C. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hyper-ERAS Program | Procedure | Patients who met the inclusion criteria were treated with Hype-ERAS protocol, including preoperative education, intraoperative quality control, postoperative preventive analgesia, early ambulation, early recovery of diet, early removal of the drainage tube, urinary catheter, and gastric tube, and discharge within 48 hours or more than 48 hours safter surgery, and closely and standardized follow-up outside the hospital. |
| Measure | Description | Time Frame |
|---|---|---|
| 30-day overall complication rate | The primary endpoint was the 30-day overall complication rate. | 30 days after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Severe complications (CD≥IIIb) rate, within 30 days after surgery | Severe complications (CD≥IIIb) rate | 30 days after surgery |
| The rehospitalization rate within 30 days after surgery | 30 days after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Changlong Li | Contact | +861088196086 | vip2nd@163.com | |
| Lin Wang, M.D. | Contact | +8613910975011 | wanglinmd@foxmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peking University Cancer Hospital & Institute | Recruiting | Beijing | Haidian District | 100142 | China |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |